Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
MIRA製藥早前報告:將在2024年10月28-29日于波士頓舉行的第18屆疼痛治療峯會上展示新的臨床前數據,顯示Ketamir-2對神經病性疼痛的100%逆轉。
Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024
MIRA製藥早前報告:將在2024年10月28-29日于波士頓舉行的第18屆疼痛治療峯會上展示新的臨床前數據,顯示Ketamir-2對神經病性疼痛的100%逆轉。